WB analysis of A431 lysate with (B) and without (A) blocking with the immunising peptide using GTX89290 EBAG9 antibody, C-term. Dilution : 0.2microg/ml Loading : 35microg protein in RIPA buffer
WB analysis of A431 lysate with (B) and without (A) blocking with the immunising peptide using GTX89290 EBAG9 antibody, C-term. Dilution : 0.2microg/ml Loading : 35microg protein in RIPA buffer
EBAG9 antibody, C-term
GTX89290
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetEBAG9
Overview
- SupplierGeneTex
- Product NameEBAG9 antibody, C-term
- Delivery Days Customer7
- Application Supplier NoteWB: 1-3microg/ml. IHC-P: 3.75microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.50 mg/ml
- ConjugateUnconjugated
- Gene ID9166
- Target nameEBAG9
- Target descriptionestrogen receptor binding site associated antigen 9
- Target synonymscancer-associated surface antigen RCAS1; EB9; estrogen receptor-binding fragment-associated gene 9 protein; PDAF; receptor-binding cancer antigen expressed on SiSo cells
- HostGoat
- IsotypeIgG
- Protein IDO00559
- Protein NameReceptor-binding cancer antigen expressed on SiSo cells
- Scientific DescriptionThis gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10. [provided by RefSeq, Jul 2013]
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203